Paul Talalay

This inventor holds 16 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Johns Hopkins University, Brassica Foundation for Chemoprotection Research, Inc., Kennedy Krieger Institute, Inc.. Active years: 1989-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Talalay. Retrieved from https://idiyas.com/inventor/paul-talalay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 8)

% Patents Active = 93.8

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 2.3

ph-index = 10

Forward Citations = 650(Granted Patents)

Company Filing History:

11 out of 3,803

Johns Hopkins University

patents

3 out of 4

Brassica Foundation for Chemoprotection Research, Inc.

patents

1 out of 22

Kennedy Krieger Institute, Inc.

patents

4. 2 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2020

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10869853 - Compositions and methods for treating autism spectrum disorders (2020-12-22),

2. 9814731 - Method for the induction of phase 2 related genes in a mammal comprising administering exemestane (2017-11-14),

3. 9585894 - Compositions comprising exemestane and novel methods of use (2017-03-07),

4. 8937050 - Methods and compositions for treatment of autism (2015-01-20),

5. 8927007 - Formulations for treatment with glucosinolates (2015-01-06),

6. 8709406 - Prevention and treatment of oxidative stress disorders by gluthathione and phase II detoxification enzymes (2014-04-29),

7. 8303949 - Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes (2012-11-06),

8. 7407986 - Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes (2008-08-05),

9. 7303770 - Cancer chemoprotective food products (2007-12-04),

10. 6242018 - Cancer Chemoprotective food products (2001-06-05),

11. 6177122 - Cancer chemoprotective food products (2001-01-23),

12. 5968567 - Method of preparing a food product from cruciferous sprouts (1999-10-19),

13. 5968505 - Cancer chemoprotective food products (1999-10-19),

14. 5725895 - Method of preparing a food product from cruciferous seeds (1998-03-10),

15. 5411986 - Chemoprotective isothiocyanates (1995-05-02),

Title: The Innovative Contributions of Paul Talalay

Introduction

Paul Talalay is a distinguished inventor based in Baltimore, MD (US), known for his significant contributions to the field of biomedical research. With a total of 16 patents to his name, Talalay has focused on developing innovative compositions and methods aimed at treating various health conditions, particularly those related to autism spectrum disorders.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Compositions and methods for treating autism spectrum disorders." This patent features compositions that include an effective amount of isothiocyanates, such as sulforaphane, or glucosinolates, which are designed to treat autism spectrum disorders in humans. The methods outlined in this patent also provide ways to prepare these compositions effectively. Another notable patent is the "Method for the induction of phase 2 related genes in a mammal comprising administering exemestane." This invention highlights the chemoprotective properties of exemestane, which can be used to protect against various non-mammary tumors and chronic diseases that are not estrogen-dependent.

Career Highlights

Throughout his career, Paul Talalay has been associated with prestigious institutions, including The Johns Hopkins University and the Brassica Foundation for Chemoprotection Research, Inc. His work has significantly advanced the understanding of how certain compounds can be utilized for health benefits, particularly in the context of cancer prevention and treatment.

Collaborations

Talalay has collaborated with notable colleagues in his field, including Jed W. Fahey and Xiangqun Gao. These partnerships have further enriched his research and contributed to the development of innovative solutions in health and medicine.

Conclusion

Paul Talalay's innovative work and numerous patents reflect his commitment to advancing medical science and improving health outcomes. His contributions continue to inspire future research and development in the field of biomedical innovation.

Profile summary based on public USPTO records.